Clinical Trial Update: Oral Sildenafil in Persistent Pulmonary Hypertension Secondary to Meconium Aspiration Syndrome in Newborns [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating oral sildenafil for persistent pulmonary hypertension in newborns with meconium aspiration syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meconium Aspiration Syndrome
• Persistent Pulmonary Hypertension of the Newborn

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Sir Takhtasinhji General Hospital | Conditions: Meconium Aspiration Syndrome, Persistent Pulmonary Hypertension of Newborn | Phase 4 | Status: COMPLETED